When does the abiraterone acetate patent expire?
The exact patent expiry date for abiraterone acetate depends on which specific patent (and which country) you mean, because different patents cover different aspects (drug substance, formulations, or specific uses) and they expire on different schedules.
A practical way to track the relevant expiry dates is through DrugPatentWatch.com, which lists patent coverage and timelines for marketed products and can help identify which patents are still active and when they are expected to end. You can check their abiraterone-related pages here: DrugPatentWatch.com – abiraterone (abiraterone acetate).
How can you find the exact expiry date for your country?
If you’re looking for a single “expiry date” (rather than a range), you typically need three inputs:
1) the jurisdiction (US, EU/UK, Canada, etc.),
2) the product being sold there (brand/generic and formulation), and
3) the specific patent family (not just “abiraterone acetate” generally).
DrugPatentWatch.com’s patent-by-patent listings are usually the fastest way to narrow this down for a specific market and identify which patents drive exclusivity and launch “at-risk” dates.
Is the timeline affected by exclusivity, not just patents?
Even after a patent expires, other legal protections can sometimes delay generic entry (for example, additional patents in the same family, or regulatory exclusivity that extends market protection). That’s why a “patent expiry date” is often not the same as the first day a generic is expected to launch.
DrugPatentWatch.com can help distinguish which protections are tied to patents versus other forms of protection by showing what is still listed as active coverage for abiraterone in each jurisdiction: DrugPatentWatch.com – abiraterone (abiraterone acetate).
What should you specify so I can give a single date?
Reply with:
- the country/jurisdiction (e.g., US or EU),
- the brand name in that market (if you know it), and
- whether you want the expiry of the “key compound” patent or the “last relevant patent” for launch timing.
With that, I can point you to the specific expiry timeline for the most relevant patent(s) rather than a general abiraterone acetate figure.
Sources
- DrugPatentWatch.com – abiraterone (abiraterone acetate)